Talk:Estrone/progesterone

Wiki Education assignment: Foundations II

This article was the subject of a Wiki Education Foundation-supported course assignment, between 5 June 2023 and 11 August 2023. Further details are available on the course page. Student editor(s): Tinarss, T.leepharmacy, Futurepharmd, Lubnakhan209 (article contribs). Peer reviewers: Jazlynquintana, Kikilinh, FatemehNovin.

— Assignment last updated by Jazlynquintana (talk) 05:53, 4 August 2023 (UTC)

Editing plans

We plan to separate the combination medication and address the following: side effects, adverse effects, contraindications, indications, availability, and pricing. Our sources will come from systematic reviews and meta- analysis. Tinarss (talk) 23:18, 25 July 2023 (UTC)

At some point we should also add headings and subheadings for the additions we put in. Thanks! T.leepharmacy (talk) 20:29, 30 July 2023 (UTC)

@Tinarss, T.leepharmacy, Futurepharmd, and Lubnakhan209: Thank you for your contributions. Please note that this article is about the combination of Estrone and Progesterone as a medication. Hence additions to this article should be specifically about the combination medication, not the invidual components. If you want to add material about the stand alone medications, these edits should be added to Estrone or Progesterone. Thanks. Boghog (talk) 20:45, 30 July 2023 (UTC)

@Boghog: Thank you for the notice on this. We are currently assigned to work on this article for a project. From prior instruction we decided on adding the information about estrone and progesterone as individual components. They are tracking the history of our updates to see the progress we are making on this page currently. We understand that this is the wrong page to add this information to, but if it is acceptable for the time being we would like to continue adding our contributions for tracking purposes. It is completely fine to have our work deleted after but please let me know your thoughts. Thanks. T.leepharmacy (talk) 21:36, 30 July 2023 (UTC)

@Boghog We made the decision to remove the edits from the main article that pertained specifically to estrone or progesterone. Instead, we included that information on separate pages dedicated to each drug. Lubnakhan209 (talk) 22:37, 1 August 2023 (UTC)

Peer Review

1. Are the points included verifiable with cited secondary sources that are freely available? After clicking through every reference in the article, I was able to infer that most of the references are secondary sources. There are a couple primary sources listed but they are always cited alongside secondary sources when referred to in the article. The sources are mostly freely available aside from books that require purchase. Looking through the content I would say that the points are verifiable as the references that were cited reflected what the point was claiming. FatemehNovin (talk) 19:25, 1 August 2023 (UTC)

2. Do the group’s edits substantially improve the article as described in the Wikipedia peer review “Guiding framework”?' Overall this group did improve the article according to the Wikipedia peer review Guiding Framework. The content added and revised are neutral and unbiased. There have been revisions in grammar and wording of the article. There are a few suggestions I would recommend. I would include the major sections of the article in the info box with brief descriptions (ex Side Effects: breast swelling, breast tenderness, vaginal itching…). I also think it would be best to keep the information (i.e. side effects, indications, etc) about the combined drug instead of separating the two components. FatemehNovin (talk) 17:53, 1 August 2023 (UTC)

3. Has the group achieved its overall goals for improvement? It seems that the group still has some goals left to fulfill but they are on a steady path. So far the article continues to improve as more content is added and revised. The technical aspects of the article have been progressing sufficiently. Areas to improve include organization, lead, and content (in terms of having information about the combined product versus the individual components). FatemehNovin (talk) 17:53, 1 August 2023 (UTC)

Thank you for your great suggestions! Because this drug is only available in a few countries, not including the US, there was a lack of sources, which is why we had no choice but to write about each drug separately. We have recently decided to move our estrone content and progesterone content to their respective articles, so now this article only has content on the combination drug. Futurepharmd (talk) 01:01, 3 August 2023 (UTC)

- Do the edits reflect language that supports diversity, equity, and inclusion? Yes, the language used in the article is appropriate. However, I think further improvement can be made by using more inclusive language, such as switching 'women' to 'individuals,' to include those who are trans, nonbinary, etc. Kikilinh (talk) 18:12, 1 August 2023 (UTC)
- Do the group's edits substantially improve the article as described in the Wikipedia peer review "Guiding framework"? Yes, the edits do improve the article from its original state, particularly in the areas of grammar and language. However, the section on Estrone would be a better addition to a separate article on Estrone itself. The leading section could be separated into different sections to give the article more structure and to replace the estrone content. Kikilinh (talk) 18:26, 1 August 2023 (UTC)
- Has the group achieved its overall goals for improvement? Overall, the group has made good improvements to the article, especially in the leading section. Further improvements can be made to the actual content by focusing the article solely on the combination product rather than its individual components. However, the technical and grammatical changes are appropriate and meet the group's goals. Kikilinh (talk) 18:26, 1 August 2023 (UTC)

This is a great suggestion, I will fix this. Thanks! T.leepharmacy (talk) 22:49, 1 August 2023 (UTC)

· Does the draft submission reflect a neutral point of view? The draft submission does reflect a neutral point of view using language and diction that supports a neutral style that is based on delivering factual information. Most sentences, if not all, are clearly factual and cited, and have no implications of bias. Jonramos6 (talk) 18:20, 1 August 2023 (UTC) · Do the group’s edits substantially improve the article as described in the Wikipedia peer review “Guiding framework”? The group's edits definitely improved the article, as they had performed grammatical revisions to the previous version of the article as well as added an entirely new section of the article pertaining to estrone. However, a good point about the article is that estrone itself as an individual component would be better suited to its own article rather than part of this current article that highlights the combination medication of estrone and progesterone. The same can be said regarding progesterone, which does not have its own section in this article like estrone does, but it would also be better suited to have its own article rather than be included in this article. Jonramos6 (talk) 18:20, 1 August 2023 (UTC) · Has the group achieved its overall goals for improvement? The group has somewhat achieved its overall goals of improvement. The goal of adding side effects, adverse effects, availability, pricing, etc., have been mostly met aside from the fact that they are indicated for estrone only and not the combination medication of estrone/progesterone. Otherwise, the formatting changes as well as the content changes have mostly met the group's goals of improvement of the article. Jonramos6 (talk) 18:20, 1 August 2023 (UTC)

Due to the limited availability of resources for this drug and its presence in only five countries, we decided to work on each drug separately. To provide more comprehensive information, we will add the details under separate drug pages. Given the shortage of secondary resources, we will make only minor edits on this main page. This approach allows readers to access more in-depth information about each drug while considering the limitations posed by the availability of resources for the combination drug. Lubnakhan209 (talk) 22:33, 1 August 2023 (UTC)

Reference Review

I edited the journal article references on this page by fixing the dates to be year-only. Futurepharmd (talk) 23:19, 4 August 2023 (UTC) As a group, we looked together for any predatory or duplicate sources and did not find any. Futurepharmd (talk) 23:19, 4 August 2023 (UTC)

I agree with @Futurepharmd Lubnakhan209 (talk) 23:21, 4 August 2023 (UTC)

I agree with @Futurepharmd T.leepharmacy (talk) 23:26, 4 August 2023 (UTC)

I agree @FuturepharmdTinarss (talk) 03:14, 5 August 2023 (UTC)

I edited #10 as it contained an invalid linked source and was replaced with a citation to a drug reference to the medication, Synergon. T.leepharmacy (talk) 23:31, 4 August 2023 (UTC)